STD Molecular Testing Lab in Nepal NAAT & PCR Diagnostics for Accurate STI Detection
Molecular STD testing using NAAT/PCR technology detects chlamydia, gonorrhea, mycoplasma, trichomoniasis, HSV, and HIV with exceptional sensitivity — including infections that older methods miss.
Medically Reviewed Content
Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)
Last medical review: November 8, 2026
Next scheduled review: May 8, 2027
This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.
Important Molecular Testing Information
- NAAT detects genetic material — a positive result after recent treatment may reflect residual DNA/RNA, not active infection; test-of-cure timing matters.
- Extragenital infections (rectal, pharyngeal) are missed by urine testing — site-specific swabs are needed for complete screening.
- A negative NAAT during the window period may miss very recent infection — timing since exposure matters.
- Positive results require clinical correlation and treatment — molecular detection alone does not determine management.
Molecular STD Testing in Nepal
- NAAT as gold standard — WHO and CDC guidelines recommend NAAT as first-line testing for chlamydia and gonorrhea; Nepal's private laboratories increasingly offer this technology.
- Asymptomatic infections — most chlamydia and many gonorrhea infections cause no symptoms; NAAT's high sensitivity detects these silent infections that older methods miss.
- Antimicrobial resistance — gonorrhea resistance is a growing global concern; accurate NAAT diagnosis ensures appropriate treatment and helps track resistance patterns.
- Emerging pathogens — Mycoplasma genitalium and other organisms previously undetectable are now identified through molecular panels, improving diagnosis of persistent symptoms.
- Quality matters — molecular testing requires strict contamination control; choosing a laboratory with genuine in-house NAAT capability versus send-out testing affects turnaround and reliability.
Molecular Testing: The Gold Standard for STI Diagnosis
Molecular testing — also called nucleic acid amplification testing (NAAT) or PCR — has transformed sexually transmitted infection diagnosis. Unlike older methods that required culturing organisms or detecting antibodies, NAAT directly detects the genetic material (DNA or RNA) of the pathogen. This makes it the most sensitive and specific method available — detecting infections that culture misses, identifying organisms that cannot be cultured at all, and providing results faster than traditional methods.
NAAT testing is now the recommended first-line method for diagnosing chlamydia and gonorrhea by major health organizations worldwide. It detects infection earlier, with higher sensitivity, from simpler samples — often urine rather than uncomfortable swabs. It also enables detection of organisms that were previously difficult or impossible to identify, including Mycoplasma genitalium, Trichomonas vaginalis, and certain viral infections. For HIV, molecular RNA testing detects infection days after exposure, weeks before serology turns positive.
In Nepal, molecular STD testing is increasingly available in Kathmandu private laboratories, complementing the public health system. The technology requires specialized equipment, trained personnel, and strict quality control to prevent contamination — factors that distinguish genuine molecular laboratories from those simply sending samples elsewhere. Accurate molecular testing is essential because STI misdiagnosis leads to either untreated infection spreading further or unnecessary treatment causing side effects and contributing to antimicrobial resistance.
This page explains what molecular STD testing is, which infections it detects, how NAAT/PCR works, why it is more accurate than older methods, what it costs in Nepal, and when molecular testing is the right choice versus other diagnostic approaches.
What NAAT/PCR Testing Is and How It Works
Nucleic acid amplification testing detects the genetic material of pathogens — DNA or RNA — rather than the organism itself or antibodies against it. The process involves extracting nucleic acids from the sample, amplifying target sequences through polymerase chain reaction (PCR) or similar techniques, and detecting the amplified product. If the pathogen's genetic material is present, it gets amplified to detectable levels; if absent, nothing is detected.
This approach offers extraordinary sensitivity — detecting as few as a handful of organisms — and specificity — distinguishing between closely related species with precision. Because it detects genetic material rather than viable organisms, NAAT can identify infections even when organisms are present in low numbers or in sites difficult to culture. The trade-off is that NAAT cannot distinguish between live and dead organisms, so it may remain positive briefly after successful treatment until residual genetic material clears.
- NAAT detects pathogen DNA or RNA directly — the most sensitive detection method available.
- PCR amplification makes even tiny amounts of genetic material detectable.
- High specificity distinguishes between closely related organisms precisely.
- Can detect non-culturable organisms that traditional methods miss entirely.
- May remain positive briefly after treatment until residual genetic material clears.
Direct Detection
NAAT finds the pathogen's genetic fingerprint — no need to grow organisms in culture or wait for antibody response.
Extreme Sensitivity
Amplification detects as few as a handful of organisms — catching infections at their earliest stage.
High Specificity
Distinguishes between species precisely — no cross-reactivity with similar organisms.
Non-Culturable Detection
Identifies organisms like Mycoplasma and Trichomonas that cannot be grown in standard culture.
Which Infections Molecular Testing Detects
NAAT is the gold standard for chlamydia and gonorrhea — detecting these bacterial infections with sensitivity far exceeding culture or microscopy. It can use urine samples for many patients, avoiding uncomfortable swabs, and detects infections at multiple anatomical sites — genital, rectal, and pharyngeal — which is critical because extragenital infections are common and often missed by urine testing alone.
Molecular panels extend detection to organisms that were previously difficult to diagnose: Mycoplasma genitalium (increasingly recognized as a cause of persistent urethritis and pelvic inflammatory disease), Trichomonas vaginalis (the most common non-viral STI, often missed by routine screening), and certain viral infections. For HIV, RNA PCR detects infection days after exposure — weeks before antibody tests turn positive.
- Chlamydia trachomatis — NAAT gold standard, urine or swab, genital and extragenital sites.
- Neisseria gonorrhoeae — NAAT detection with antibiotic susceptibility considerations.
- Mycoplasma genitalium — emerging pathogen causing persistent urethritis and PID.
- Trichomonas vaginalis — most common non-viral STI, frequently missed by routine tests.
- Herpes simplex virus — lesion PCR for active sores, blood antibody for past exposure.
- HIV RNA — detects infection days after exposure, before serology turns positive.
- Hepatitis C RNA — confirms active infection and monitors treatment response.
Chlamydia & Gonorrhea
NAAT is the recommended first-line test — highest sensitivity, simplest sampling, and detection at all anatomical sites.
Mycoplasma genitalium
Previously undetectable, now identified through molecular panels — explains many cases of persistent symptoms.
Trichomoniasis
The most common non-viral STI, often missed by routine screening — NAAT detects it accurately.
Viral Detection
HIV RNA and HSV PCR detect viral infections at their earliest stages or from active lesions.
Why Molecular Testing Outperforms Older Methods
Culture — the traditional method for bacterial STIs — requires living organisms to grow in laboratory conditions. Many STI organisms are difficult or impossible to culture, cultures take days to weeks for results, and antibiotic sensitivity testing requires viable organisms. NAAT eliminates all these limitations — detecting genetic material regardless of organism viability, producing results in hours, and not requiring culture for diagnosis.
Serology — detecting antibodies — has fundamental limitations for acute infection diagnosis. Antibodies take time to develop, may never reach detectable levels in some patients, and cannot distinguish between current and past infection for some organisms. NAAT detects the pathogen itself, making it superior for diagnosing active infection. The combination of higher sensitivity, faster turnaround, simpler sampling, and detection of non-culturable organisms makes NAAT the clear choice for modern STI diagnosis.
- Culture takes days-weeks; NAAT produces results in hours.
- Many STI organisms cannot be cultured — NAAT detects them anyway.
- Serology detects antibodies not infection — NAAT detects the pathogen directly.
- Antibody tests miss early infection and cannot distinguish current vs. past exposure.
- NAAT enables multi-organism panels detecting several infections simultaneously.
Speed
Results in hours versus days for culture — faster diagnosis means faster treatment and less transmission.
Sensitivity
Detects infections that culture misses — particularly important for asymptomatic carriers.
Direct Detection
Finds the pathogen itself rather than indirect markers like antibodies — more definitive for active infection.
Comprehensive Panels
Multi-organism molecular panels detect several infections from one sample simultaneously.
Sample Types, Sites, and Testing Considerations
NAAT offers remarkable flexibility in sample types. First-catch urine is the preferred sample for genital chlamydia and gonorrhea testing in many situations — simple, comfortable, and highly sensitive. Vaginal swabs (self-collected or clinician-collected) work equally well. Rectal and pharyngeal swabs are essential for detecting extragenital infections — critical for men who have sex with men and anyone with relevant exposures, since these sites are frequently infected but missed by urine testing alone.
Testing site selection matters enormously. A patient with genital symptoms might have concurrent rectal or pharyngeal infection that urine testing misses. Comprehensive sexual health assessment considers all potential exposure sites. For women, vaginal swabs are preferred over cervical swabs for NAAT — equally accurate and more comfortable. Proper sample collection technique is essential for accurate results — insufficient sample or incorrect collection leads to false negatives even with perfect laboratory analysis.
- First-catch urine — preferred for genital chlamydia/gonorrhea, simple and comfortable.
- Vaginal swabs — self-collection possible, equally accurate as clinician-collected.
- Rectal swabs — essential for detecting rectal infections missed by urine testing.
- Pharyngeal swabs — detect throat infections from oral sex.
- Multi-site testing — comprehensive screening requires testing all exposure sites.
- Proper collection — incorrect technique causes false negatives regardless of lab quality.
Urine Testing
First-catch urine detects genital chlamydia and gonorrhea with high sensitivity — no swab needed for many patients.
Self-Collection
Vaginal swabs can be self-collected comfortably at home or in clinic — equally accurate as clinician collection.
Extragenital Sites
Rectal and pharyngeal infections are common but missed by urine testing — site-specific swabs are essential.
Comprehensive Screening
Testing all exposure sites provides complete infection picture — genital-only testing misses extragenital infections.
Costs and Access in Nepal
Molecular STD testing in Kathmandu is priced per test or per panel, reflecting the technology's complexity. Individual NAAT tests for chlamydia or gonorrhea typically cost Rs. 1,000–2,500; multi-organism panels covering chlamydia, gonorrhea, mycoplasma, and trichomoniasis range Rs. 3,000–8,000; HIV RNA PCR costs Rs. 2,500–5,000; and viral load testing for diagnosed patients Rs. 3,000–8,000. Prices vary by laboratory, panel composition, and whether testing is performed in-house or sent to reference laboratories.
Access to molecular testing is concentrated in Kathmandu private laboratories with genuine in-house NAAT capability. Some laboratories send samples to reference labs — this adds turnaround time and may affect sample integrity. When choosing a molecular testing laboratory, ask whether NAAT is performed on-site, what quality control procedures are in place, and what the realistic turnaround time is. Home sample collection is available for privacy, and digital reports deliver results securely.
- Individual NAAT (chlamydia/gonorrhea): Rs. 1,000–2,500.
- Multi-organism panel (CT, GC, Mgen, TV): Rs. 3,000–8,000.
- HIV RNA PCR: Rs. 2,500–5,000.
- HIV viral load: Rs. 3,000–8,000.
- Turnaround: typically 1–3 working days for molecular tests.
- In-house vs. send-out testing affects turnaround and sample integrity.
Transparent Pricing
Clear NPR costs per test or panel — ask whether testing is in-house or sent out when comparing prices.
In-House Advantage
Laboratories performing NAAT on-site offer faster turnaround and better sample integrity than send-out testing.
Quality Verification
Ask about contamination controls, quality assurance, and accreditation — molecular testing requires stringent quality systems.
Convenient Access
Home sample collection and digital reports make molecular testing accessible without clinic visits.
Molecular STD Testing Services
| Service | What It Includes | Cost (NPR) |
|---|---|---|
| Chlamydia NAAT | Nucleic acid amplification — urine or swab, genital or extragenital site. | Rs. 1,000–2,000 |
| Gonorrhea NAAT | Nucleic acid amplification — urine or swab, genital or extragenital site. | Rs. 1,000–2,000 |
| CT/GC Dual NAAT | Combined chlamydia and gonorrhea testing — most common STI screen. | Rs. 1,500–3,000 |
| Multi-Organism STI Panel | Chlamydia, gonorrhea, Mycoplasma genitalium, Trichomonas vaginalis. | Rs. 3,000–8,000 |
| HIV RNA PCR (Qualitative) | Detects HIV genetic material — earliest detection and confirmation. | Rs. 2,500–5,000 |
| HIV RNA PCR (Quantitative) | Viral load measurement — monitors treatment in diagnosed patients. | Rs. 3,000–8,000 |
| Herpes Lesion PCR | Detects HSV DNA from active sores — definitive lesion diagnosis. | Rs. 1,500–3,000 |
| Rectal/Pharyngeal NAAT | Site-specific testing for extragenital infections. | Rs. 1,000–2,000 per site |
Indicative NPR pricing. Turnaround typically 1–3 working days. Ask whether testing is performed in-house.
Why Patients Choose Thamel Clinic
- Genuine molecular capability — NAAT/PCR performed with modern equipment and strict contamination controls.
- Multi-organism panels — detect several infections simultaneously including emerging pathogens.
- All anatomical sites — genital, rectal, and pharyngeal testing for complete infection picture.
- High sensitivity — detects infections that culture and older methods miss, including asymptomatic carriers.
- Fast turnaround — results in 1–3 days rather than weeks for culture-based testing.
- Confidential service — completely private testing with secure digital reports and no disclosure.
- Transparent Kathmandu pricing — clear costs per test with package options for comprehensive screening.
Relevant Specialist Expertise
These clinicians provide care within their scope of practice at our clinic.

Dr. Amrita Shrestha
Consultant Dermatologist and Venereologist
Dr. Amrita Shrestha is a Consultant Dermatologist and Venereologist and an MD Dermatology Gold Medalist from Tribhuvan University, Institute of Medicine, Maharajgunj Medical Campus. Her clinical work spans general and clinical dermatology, sexually transmitted infections, HIV-associated skin conditions, leprosy and neglected tropical diseases, and complex dermatological emergencies.
Key Expertise
Frequently Asked Questions
What is NAAT testing for STDs?
NAAT (nucleic acid amplification testing) detects the genetic material of pathogens directly — DNA or RNA — rather than growing organisms or detecting antibodies. It is the most sensitive and specific method available, detecting infections that culture misses and identifying organisms that cannot be cultured at all. It is the recommended first-line test for chlamydia and gonorrhea.
How much does molecular STD testing cost in Nepal?
Individual NAAT tests for chlamydia or gonorrhea cost Rs. 1,000–2,500. Multi-organism panels covering chlamydia, gonorrhea, mycoplasma, and trichomoniasis range Rs. 3,000–8,000. HIV RNA PCR costs Rs. 2,500–5,000 and viral load Rs. 3,000–8,000. Prices vary by laboratory and whether testing is in-house or sent out.
Is NAAT more accurate than culture for STI testing?
Yes — significantly. NAAT has higher sensitivity (detects more true infections), faster turnaround (hours vs. days-weeks), simpler sampling (urine vs. swabs), and can detect non-culturable organisms. Culture is still used for antibiotic sensitivity testing in specific situations, but NAAT is the recommended diagnostic method for most STI testing.
Can NAAT detect infections that have no symptoms?
Yes — this is one of its greatest advantages. Most chlamydia and many gonorrhea infections cause no symptoms, and NAAT's high sensitivity detects these silent infections that culture and microscopy miss. Asymptomatic carriers can transmit infection without knowing it — NAAT screening identifies them for treatment.
What is the difference between NAAT and PCR?
NAAT is the general category of tests that amplify nucleic acids; PCR (polymerase chain reaction) is the most common NAAT technique. When people say "PCR test" for STDs, they typically mean NAAT. Other amplification methods exist but PCR is the dominant technology in clinical laboratories.
How long do molecular STD test results take?
Most molecular tests produce results in 1–3 working days. Some laboratories offer faster turnaround for urgent cases. The exact timeframe depends on whether testing is performed in-house or sent to a reference laboratory — in-house testing is typically faster.
Do I need a swab or can I provide urine for NAAT?
For genital chlamydia and gonorrhea, first-catch urine is often sufficient and preferred — simple and comfortable. For rectal or pharyngeal infections, site-specific swabs are required. Vaginal swabs are an option for women. Your clinician determines which sample types are appropriate based on your exposure history.
Can NAAT detect multiple infections at once?
Yes — multi-organism molecular panels test for several infections simultaneously from one sample. Panels can include chlamydia, gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis together. This provides comprehensive screening more efficiently than individual tests.
Why does my NAAT test remain positive after treatment?
NAAT detects genetic material, not living organisms. After successful treatment, residual DNA or RNA can persist for days to weeks before clearing. This is why test-of-cure for chlamydia and gonorrhea is typically done 3–4 weeks after treatment, not immediately — giving time for residual genetic material to clear.
Are molecular STD tests confidential?
Completely. All testing is strictly confidential — samples, results, and consultation content are never shared with family, employers, or anyone else without your written consent. Digital reports are securely accessible only to you.
Still have questions? Contact us or book an appointment for personalized guidance.
Related Services & Guides
PCR/NAAT STD Lab
Laboratories specializing in molecular STI testing.
Advanced Molecular STD Lab
State-of-the-art molecular diagnostics for STIs.
PCR STD Test
Detailed guide to PCR-based STI testing.
Complete STD Panel
Comprehensive multi-infection screening panels.
STD Diagnostic Lab
Full-range STD testing and diagnosis services.
High-Sensitivity STD Tests
Most sensitive STI detection methods available.
STD Clinic
Testing, treatment, and follow-up care together.
Book a Molecular Test
Schedule NAAT/PCR STI testing online.
Related Health Guides
Medical Review & Sources
Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)
Role: Molecular diagnostics and STI reviewers, Thamel Clinic, Kathmandu
Last reviewed: 2026-11-08
Reviewed against current WHO and CDC STI testing guidelines. This is general medical information; a registered clinician must assess each patient before treatment.
References
- STI Treatment Guidelines — CDC, 2021
- Sexually transmitted infections — World Health Organization, 2023
Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.
Medical Disclaimer
Important information about using this medical website
Educational Purpose Only
The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
No Doctor-Patient Relationship
Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Emergency Situations
If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.
Emergency Contact Information:
National Emergency:
102 (Ambulance)
Our Clinic:
+977-9700682800 (WhatsApp available 24/7)
Bir Hospital Emergency:
+977-1-4412400
TU Teaching Hospital:
+977-1-4434320
Timeliness of Information
Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.
Professional Medical Advice Required
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.
Treatment and Diagnosis
Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.
Limitation of Liability
In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.
Nepal-Specific Considerations
This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.
Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered